Results 201 to 210 of about 130,433 (287)

Sex Differences in Response to Viral Vector Vaccines—Implications for Future Vaccine Design

Immunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT Vaccination represents one of the most impactful public health achievements, preventing 3.5 to 5 million deaths annually according to estimates of the World Health Organization. Yet, recent outbreaks of emerging and reemerging infectious diseases highlight the need for rapid and strategic vaccine development using vaccine platforms ...
Ilka Grewe, Tamara Zoran, Marylyn Martina Addo   +2 more
wiley   +1 more source

Measuring adult mortality from mobile phone surveys in Burkina Faso, Malawi and the Democratic Republic of the Congo. [PDF]

BMJ Glob Health
Dianou K, Masquelier B, Luhar S, Lankoandé B, Menashe-Oren A, Soura A, Bassinga H, Tlhajoane M, Dulani B, Akilimali PZ, Reniers G.   +10 more
europepmc   +1 more source

Can Flash Flood Risk Index Be an Early Warning Signal of Flash Floods in Ungauged Basin?

Journal of Flood Risk Management, Volume 19, Issue 1, March 2026.
ABSTRACT Flash flooding is amongst the most severe natural hazards, causing widespread socioeconomic impacts across both wet regions and drylands. In ungauged mountainous basins, effective risk warning based on hydrodynamic modelling is challenging due to sparse hydrological observations and complex terrain.
Kaihua Guo, Mingfu Guan, Jie Yin
wiley   +1 more source

Seven Strategies Implemented in Response to the 16th Ebola Virus Disease Outbreak in the Democratic Republic of Congo: Lessons Learned over a Three-Month Period. [PDF]

Viruses
Mwamba DK, Angendu KB, Diouf W, Mikobi MC, Leonard O, Kalala D, Ntumba N, Kakule D, Kayembe DK, Sana E, Kabasele B, Katya J, Montoyo A, Serra B, Bulambo H, Otshudiema J, Kapanga S, Balayulu O, Muya J, Kamangu E, Kitenge R, Tshapenda G, Kasita C, Keita M, Kabasubabo FK, Kombe J, Mossoko M, Ngandu CB, Manianga C, Moullec G, Zarowsky C, Akilimali PZ.   +31 more
europepmc   +1 more source

Evaluating the Genetic Overlap Between Congenital Heart Disease and Neuroblastoma Risk

Pediatric Blood &Cancer, Volume 73, Issue 2, February 2026.
ABSTRACT Children with congenital heart disease (CHD) have elevated neuroblastoma (NB) risk, potentially due to shared neural crest origins. We analyzed rare exonic de novo single‐nucleotide variants in 702 CHD and 454 NB trios from the Neuroblastoma Epidemiology in North America Study, Gabriella Miller Kids First Program, and a published cohort. Seven
Ji Yun Tark, Alexander Renwick, Yao Yu, Aniko Sabo, Andrew F. Olshan, Sharon E. Plon, Chad D. Huff, Philip J. Lupo   +7 more
wiley   +1 more source

The 2024-2025 upsurge of mpox in Africa: another opportunity to accelerate global solidarity for a neglected disease. [PDF]

BMJ Glob Health
Onyeaghala C, Iroezindu M.
europepmc   +1 more source

Population pharmacokinetics of artemether–lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 589-605, February 2026.
Aims Resistance to the artemisinins and the artemisinin‐based combination therapy (ACT) partner drugs has developed in Southeast Asia, and artemisinin resistance has also emerged in eastern Africa. Triple ACTs (triple artemisinin‐based combination therapies, TACT), consisting of two partner drugs with different mechanisms of action and similar ...
Junjie Ding, Richard M. Hoglund, Rob W. van der Pluijm, James J. Callery, Thomas J. Peto, Rupam Tripura, Sukanta Das, Nguyễn Hoàng Châu, Cholrawee Promnarate, Mavuto Mukaka, Lek Dysoley, Caterina Fanello, Marie A. Onyamboko, Anupkumar R. Anvikar, Mayfong Mayxay, Frank Smithuis, Lorenz von Seidlein, Mehul Dhorda, Chanaki Amaratunga, M. Abul Faiz, Ho Dang Trung Nghia, Nicholas J. White, Nicholas P. J. Day, Arjen M. Dondorp, Joel Tarning   +24 more
wiley   +1 more source

Links between infrastructure for human movement and early Ebola outbreak trajectories. [PDF]

Sci Rep
Gonzalez A, Nikparvar B, Matson MJ, Baranowski K, Seifert SN, Ross HD, Munster V, Bharti N.   +7 more
europepmc   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 329-347, February 2026.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, Stefanie Lip, Hannah O'Neill, Kerry Burke, Vicky Chaplin, Alexander S. F. Doney, Salim Elyas, Nicholas Greaves, Sophie Harding, David Hargroves, Judith Hayward, Dyfrig A. Hughes, Tom A. T. Hughes, Sree Kondapally, Patrick Mok, Aaron Peace, Imran Rafi, Simon Ray, Vicky Stinton, Luigi Venetucci, Munir Pirmohamed   +22 more
wiley   +1 more source

Peritoneal dialysis influences microRNA expression and pro-inflammatory response: results from a cross-sectional study. [PDF]

J Bras Nefrol
Costa NA, Pereira AG, Rodrigues HCN, Cuppari L, Felix TF, Minutentag IW, Reis PP, Balbi AL, Polegato BF, Azevedo PS, Zornoff LAM, Paiva SAR, Ponce D, Rogero MM, Minicucci MF.   +14 more
europepmc   +1 more source